A systematic review on the association of serum selenium and metabolic syndrome

Journal of Research in Medical Sciences

Volumn 20, Issue 8, 2015, Pages 782-789

  Tajaddini, Mohammad Hasan ^a   Keikha, Mojtaba ^b   Razzazzadeh, Ali ^c   Kelishadi, Roya ^b  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Metabolic syndrome; Prevention; Selenium; Systematic review

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR 1; SELENIUM; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL;

ATHEROSCLEROSIS; BODY MASS; CLINICAL TRIAL (TOPIC); DIETARY INTAKE; HUMAN; HYPERTENSION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PSORIASIS; REVIEW; SCHIZOPHRENIA; SYSTEMATIC REVIEW; THROMBOSIS; WAIST HIP RATIO;

EID: 84944750304     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: 10.4103/1735-1995.168403     Document Type: Review

References (51)

1. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndromeLancet 2005;365:1415-28.
2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
3. Ahluwalia N, Drouet L, Ruidavets JB, Perret B, Amar J, Boccalon Het al. Metabolic syndrome is associated with markers of subclinical atherosclerosis in a French population-based sampleAtherosclerosis 2006;186:345-53.
4. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-9.
5. Delavari A, Forouzanfar MH, Alikhani S, Sharifian A, Kelishadi RFirst nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the middle eastThe national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care 2009;32:1092-7.
6. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PAStern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992;41:715-22.
7. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén Met al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001;24:683-9.
8. Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo ETuomilehto J, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-16.
9. Trevisan M, Liu J, Bahsas FB, Menotti A. Syndrome X and mortality: A population-based study. Risk Factor and Life Expectancy Research Group. Am J Epidemiol 1998;148:958-66.
10. Wilson PW, Kannel WB, Silbershatz H, D’Agostino RB. Clustering of metabolic factors and coronary heart disease. Arch Intern Med 1999;159:1104-9.
11. Oberley LW. Free radicals and diabetes. Free Radic Biol Med 1988;5:113-24.
12. Rao AV. Lycopene, tomatoes, and the prevention of coronary heart disease. Exp Biol Med (Maywood) 2002;227:908-13.
13. Brenneisen P, Steinbrenner H, Sies H. Selenium, oxidative stressand health aspects. Mol Aspects Med 2005;26:256-67.
14. Fulop T, Tessier D, Carpentier A. The metabolic syndrome. Pathol Biol (Paris) 2006;54:375-86.
15. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: The link between insulin resistance, obesity and diabetes. Trends Immunol 2004;25:4-7.
16. Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R. Metabolic syndrome: A comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 2005;111:1448-54.
17. Guzik TJ, Mangalat D, Korbut R. Adipocytokines – Novel link between inflammation and vascular function? J Physiol Pharmacol 2006;57:505-28.
18. Puchau B, Zulet MA, González de Echávarri A, Navarro-Blasco IMartínez JA. Selenium intake reduces serum C3, an early marker of metabolic syndrome manifestations, in healthy young adultsEur J Clin Nutr 2009;63:858-64.
19. Zulet MA, Puchau B, Navarro C, Martí A, Martínez JAInflammatory biomarkers: The link between obesity and associated pathologies. Nutr Hosp 2007;22:511-27.
20. Reitman A, Friedrich I, Ben-Amotz A, Levy Y. Low plasma antioxidants and normal plasma B vitamins and homocysteine in patients with severe obesity. Isr Med Assoc J 2002;4:590-3.
21. Beaglehole R, Jackson R, Watkinson J, Scragg R, Yee RL. Decreased blood selenium and risk of myocardial infarction. Int J Epidemiol 1990;19:918-22.
22. van de Vtver LP, Kardinaal AF, Grobbee DE, Princen HM, van Poppel G. Lipoprotein oxidation, antioxidants and cardiovascular risk: Epidemiologic evidence. Prostaglandins Leukot Essent Faty Acids 1997;57:479-87.
23. Steinbrenner H, Sies H. Protection against reactive oxygen species by selenoproteins. Biochim Biophys Acta (BBA) Gen Subj 2009;1790:1478-85.
24. Rayman MP. Food-chain selenium and human health: Emphasis on intake. Br J Nutr 2008;100:254-68.
25. Molnar J, Garamvolgyi Z, Herold M, Adanyi N, Somogyi A, Rigo J Jr. Serum selenium concentrations correlate significantly with inflammatory biomarker high-sensitive CRP levels in Hungarian gestational diabetic and healthy pregnant women at mid-pregnancy. Biol Trace Elem Res 2008;121:16-22.
26. Rayman MP. The importance of selenium to human health. Lancet 2000;356:233-41.
27. Spallholz JE, Boylan LM, Larsen HS. Advances in understanding selenium’s role in the immune system. Ann N Y Acad Sci 1990;587:123-39.
28. Nève J. Selenium as a risk factor for cardiovascular diseases. J Cardiovasc Risk 1996;3:42-7.
29. Kiremidjian-Schumacher L, Roy M, Wishe HI, Cohen MW, Stotzky G. Supplementation with selenium and human immune cell functions. II. Effect on cytotoxic lymphocytes and natural killer cells. Biol Trace Elem Res 1994;41:115-27.
30. Guimarães MJ, Peterson D, Vicari A, Cocks BG, Copeland NG, Gilbert DJ, et al. Identification of a novel selD homolog from eukaryotes, bacteria, and archaea: Is there an autoregulatory mechanism in selenocysteine metabolism? Proc Natl Acad Sci U S A 1996;93:15086-91.
31. Esposito K, Ciotola M, Maiorino MI, Giugliano D. Lifestyle approach for type 2 diabetes and metabolic syndrome. Curr Atheroscler Rep 2008;10:523-8.
32. Hughes K, Choo M, Kuperan P, Ong CN, Aw TC. Cardiovascular risk factors in non-insulin-dependent diabetics compared to nondiabetic controls: A population-based survey among Asians in Singapore. Atherosclerosis 1998;136:25-31.
33. Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic syndrome and antioxidant concentrations: Findings from the third National Health and Nutrition Examination Survey. Diabetes 2003;52:2346-52.
34. Vidovic B, Dordevic B, Milovanovic S, Škrivanj S, Pavlovic Z, Stefanovic A, et al. Selenium, zinc, and copper plasma levels in patients with schizophrenia: Relationship with metabolic risk factors. Biol Trace Elem Res 2013;156:22-8.
35. Obeid O, Elfakhani M, Hlais S, Iskandar M, Batal M, Mouneimne Y, et al. Plasma copper, zinc, and selenium levels and correlates with metabolic syndrome components of lebanese adults. Biol Trace Elem Res 2008;123:58-65.
36. Arnaud J, de Lorgeril M, Akbaraly T, Salen P, Arnout J, Cappuccio FP, et al. Gender differences in copper, zinc and selenium status in diabetic-free metabolic syndrome European population – The IMMIDIET study. Nutr Metab Cardiovasc Dis 2012;22:517-24.
37. Zulet MA, Puchau B, Hermsdorff HH, Navarro C, Martínez JA. Dietary selenium intake is negatively associated with serum sialic acid and metabolic syndrome features in healthy young adults. Nutr Res 2009;29:41-8.
38. Puchau B, Zulet MA, Hermsdorff HH, Navarro-Blasco I, Martínez JA. Nail antioxidant trace elements are inversely associated with inflammatory markers in healthy young adults. Biol Trace Elem Res 2010;133:304-12.
39. Puchau B, Zulet MA, de Echávarri AG, Hermsdorff HH, Martínez JA. Dietary total antioxidant capacity is negatively associated with some metabolic syndrome features in healthy young adults. Nutrition 2010;26:534-41.
40. Puchau B, Zulet MA, Urtiaga G, Navarro-Blasco I, Martínez JA. Asymmetric dimethylarginine association with antioxidants intake in healthy young adults: A role as an indicator of metabolic syndrome features. Metabolism 2009;58:1483-8.
41. Mutakin, Meiliana A, Wijaya A, Kobayashi K, Yamazaki C, Kameo S, et al. Association between selenium nutritional status and metabolic risk factors in men with visceral obesity. J Trace Elem Med Biol 2013;27:112-6.
42. Ghayour-Mobarhan M, Taylor A, Lanham-New S, Lamb DJ, Nezhad MA, Kazemi-Bajestani SM, et al. Serum selenium and glutathione peroxidase in patients with obesity and metabolic syndrome. Pak J Nutr 2008;7:112-7.
43. Skroza N, Proietti I, Bernardini N, La Viola G, Nicolucci F, Pampena R, et al. Efficacy of food supplement to improve metabolic syndrome parameters in patients affected by moderate to severe psoriasis during anti-TNFa treatment. G Ital Dermatol Venereol 2013;148:661-5.
44. Czernichow S, Vergnaud AC, Galan P, Arnaud J, Favier A, Faure H, et al. Effects of long-term antioxidant supplementation and association of serum antioxidant concentrations with risk of metabolic syndrome in adults. Am J Clin Nutr 2009;90:329-35.
45. Basu A, Bets NM, Mulugeta A, Tong C, Newman E, Lyons TJ. Green tea supplementation increases glutathione and plasma antioxidant capacity in adults with the metabolic syndrome. Nutr Res 2013;33:180-7.
46. Silva TR, Alves BC, Maturana MA, Spritzer PM. Healthier dietary pattern and lower risk of metabolic syndrome in physically active postmenopausal women. J Am Coll Nutr 2013;32:287-95.
47. Perez-Cornago A, Zulet MA, Martinez JA. Association between mood and diet quality in subjects with metabolic syndrome participating in a behavioural weight-loss programme: A crosssectional assessment. Nutr Neurosci 2015;18:137-44.
48. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med 2004;350:2362-74.
49. Kelishadi R, Ardalan G, Gheiratmand R, Adeli K, Delavari A, Majdzadeh R; Caspian Study Group. Paediatric metabolic syndrome and associated anthropometric indices: The CASPIAN study. Acta Paediatr 2006;95:1625-34.
50. Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, et al. The metabolic syndrome in children and adolescents – An IDF consensus report. Pediatr Diabetes 2007;8:299-306.
51. Bates CJ, Prentice A, Cole TJ, van der Pols JC, Doyle W, Finch S, et al. Micronutrients: Highlights and research challenges from the 1994-5 National Diet and Nutrition Survey of people aged 65 years and over. Br J Nutr 1999;82:7-15.